CG Oncology (CGON) Institutional Ownership → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free CGON Stock Alerts $29.98 -0.99 (-3.20%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for CG Oncology (NASDAQ:CGON)CurrentInstitutional OwnershipPercentage26.56%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$650.13MNumber ofInstitutional Sellers(last 12 months)0 Skip Chart & View Institutional Buying and Selling Data CGON Institutional Buying and Selling by Quarter Ad InvestorPlaceCrypto Pioneer Says: “The last crypto bull market has begun.”Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… CG Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 RA Capital Management L.P.1,397,433$61.35M0.8%N/A2.097% 5/16/2024 California State Teachers Retirement System2,341$103K0.0%N/A0.004% 5/16/2024 Janus Henderson Group PLC1,521,432$66.76M0.0%N/A2.283% 5/16/2024 BVF Inc. IL1,884,191$82.72M2.3%N/A2.827% 5/16/2024 Blackstone Inc.25,000$1.10M0.0%N/A0.038% 5/15/2024 Price T Rowe Associates Inc. MD992,118$43.56M0.0%N/A1.489% 5/15/2024 Avoro Capital Advisors LLC700,000$30.73M0.4%N/A1.050% 5/14/2024 StemPoint Capital LP40,723$1.79M0.5%N/A0.061% 5/14/2024 Decheng Capital LLC5,458,810$239.64M32.1%N/A8.191% 5/14/2024 American International Group Inc.306,226$13.44M0.0%N/A0.460% 5/13/2024 Ameritas Investment Partners Inc.2,320$102K0.0%N/A0.003% 5/10/2024 Vanguard Group Inc.2,225,018$97.68M0.0%N/A3.339% 5/7/2024 TimesSquare Capital Management LLC224,073$9.84M0.1%N/A0.336% 5/1/2024 Capstone Investment Advisors LLC18,354$806K0.0%N/A0.028% 5/1/2024 BNP Paribas Financial Markets11,198$492K0.0%N/A0.017% (Data available from 1/1/2016 forward) CGON Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CGON shares? During the previous two years, 15 institutional investors and hedge funds held shares of CG Oncology. The most heavily invested institutionals were Decheng Capital LLC ($239.64M), Vanguard Group Inc. ($97.68M), BVF Inc. IL ($82.72M), Janus Henderson Group PLC ($66.76M), RA Capital Management L.P. ($61.35M), Price T Rowe Associates Inc. MD ($43.56M), and Avoro Capital Advisors LLC ($30.73M).Learn more on CGON's institutional investors. What percentage of CG Oncology stock is owned by institutional investors? 26.56% of CG Oncology stock is owned by institutional investors. Learn more on CGON's institutional investor holdings. Which institutional investors have been buying CG Oncology stock? Of the 15 institutional investors that purchased CG Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($5.46M), Vanguard Group Inc. ($2.23M), BVF Inc. IL ($1.88M), Janus Henderson Group PLC ($1.52M), RA Capital Management L.P. ($1.40M), Price T Rowe Associates Inc. MD ($992.12K), and Avoro Capital Advisors LLC ($700K). How much institutional buying is happening at CG Oncology? Institutional investors have bought a total of 14,809,237 shares in the last 24 months. This purchase volume represents approximately $650.13M in transactions. Related Companies: Fusion Pharmaceuticals Institutional Ownership Ginkgo Bioworks Institutional Ownership Novavax Institutional Ownership Inhibrx Institutional Ownership Beam Therapeutics Institutional Ownership Sana Biotechnology Institutional Ownership ADMA Biologics Institutional Ownership Neumora Therapeutics Institutional Ownership Kymera Therapeutics Institutional Ownership Tarsus Pharmaceuticals Institutional Ownership This page (NASDAQ:CGON) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarShocking: One AI startup's revenue could surge 4,735%Manward PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist My Default Watchlist Adding CG Oncology, Inc. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
